Chapter 5: Problem 2
What is the volume of vitreous cavity on average? a. \(2 \mathrm{~mL}\) b. \(4 \mathrm{~mL}\) c. \(6 \mathrm{~mL}\) d. \(8 \mathrm{~mL}\) e. \(10 \mathrm{~mL}\)
Chapter 5: Problem 2
What is the volume of vitreous cavity on average? a. \(2 \mathrm{~mL}\) b. \(4 \mathrm{~mL}\) c. \(6 \mathrm{~mL}\) d. \(8 \mathrm{~mL}\) e. \(10 \mathrm{~mL}\)
All the tools & learning materials you need for study success - in one app.
Get started for freeWhich substance found in the eye is not uveitogenic? a. S-antigen (arrestin) b. TGF- \(\beta\) c. interphotoreceptor retinoid-binding protein (IRBP) d. recoverin e. phosduscin
Which molecules do not possess immunosuppressive properties? a. free cortisol b. IL-1 receptor antagonist c. substance \(P\) d. rhodopsin e. vasoactive intestinal peptide
Which statement is not true regarding immune privilege? a. The phenomenon of immune privilege was initially described in the nineteenth century. b. Immune privilege is defined as a prolonged, sometimes indefinite, survival of organ or tissue grafts at special body/organ sites. c. Immune privilege is a dynamic process maintained by anatomic structures and immunoregulatory forces. d. Grafts placed in immune privileged sites remain sequestered from the immune environment. e. Both active and passive factors of immune privileged sites and tissues contribute to the privileged status.
How many compartments the eye contains? a. Three: cornea, anterior chamber and posterior chamber b. Two: anterior and posterior chamber c. Four: cornea, anterior chamber, posterior chamber and vitreous cavity d. Three: anterior chamber, posterior chamber and vitreous cavity
All the following is true about anterior chamber immune associated deviation (ACAID) except: a. ACAID is an antigen-specific systemic immune response to eye-derived antigens. b. ACAID is an actively acquired and actively maintained manifestation of ocular immune privilege. c. In ACAID aqueous humor possesses immunomodulatory properties and inhibits all immune reactions. d. ACAID is a form of peripheral tolerance, unlike central tolerance, where clonal deletion and/or anergy occur within the thymus. e. Once induced, ACAID persists for a very long period of time.
What do you think about this solution?
We value your feedback to improve our textbook solutions.